This was the stock's second consecutive day of losses.

Baxter International Inc. closed 29.99% short of its 52-week high of $44.01, which the company reached on March 8th.

Baxter International Inc. appeared undervalued with a P/E of 17.7 and over 2% dividend, but deeper analysis revealed it as a potential value trap. Despite strong revenue growth, Baxter struggles ...

Baxter International Inc. (NYSE:BAX – Get Free Report) has been assigned an average recommendation of “Hold” from the ten brokerages that are covering the stock, MarketBeat.com reports. One equities ...

Baxter International Inc. (BAX), a healthcare company, Monday announced the appointment of Lead Independent Director Brent Shafer as ...

Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...

Baxter International’s BAX0.67%increase; green up pointing triangle long-time leader, Jose Almeida, has abruptly retired as chairman, president and chief executive of the medical-products maker.

Investing.com -- Baxter International Inc. (NYSE:BAX), a global leader in medical technology, announced today the immediate retirement of José (Joe) E. Almeida, the company's chair, president ...

Baxter International said it weighing the potential impact of the Trump administration's planned tariffs on the medical-products maker's guidance. Baxter on Monday said it stands by its 2025 goals ...

DEERFIELD, Ill., February 03, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief ...